ophthalmologyОфтальмологияOphthalmology in Russia1816-50952500-0845Ophthalmology10.18008/1816-5095-2021-3S-630-637ophthalmology-1633Research ArticleСтатьиОсобенности факохирургии при макулярной патологии. Часть 2. Возможности оптической коррекцииFeatures of Phacosurgery in Macular Pathology. Part 2. Сapabilities of Optical Correctionhttps://orcid.org/0000-0003-4043-456XЮсефЮсеф НаимYusefYusef Naim

Юсеф Наим Юсеф, доктор медицинских наук, директор, руководитель отдела современных методов лечения в офтальмологии 

ул. Россолимо, 11а, б, Москва, 119021

Yusef Naim Yusef, MD, director, head of the Modern Treatment Methods in Ophthalmology Department 

Rossolimo str., 11A, B, Moscow, 119021

ВоробьеваМ. В.VorobyevaM. V.

Воробьева Майя Вячеславовна, кандидат медицинских наук, научный сотрудник отдела современных методов лечения в офтальмологии

ул. Россолимо, 11а, б, Москва, 119021

Vorobyeva Mayya V., РhD, research officer of the Modern Treatment Methods in Ophthalmology Department 

Rossolimo str., 11A, B, 119021, Moscow

vorobyova@mail.ruКазарянЭ. Э.KazaryanE. E.

Казарян Элина Эдуардовна, доктор медицинских наук, старший научный сотрудник отдела современных методов лечения в офтальмологии 

ул. Россолимо, 11а, б, Москва, 119021

Kazaryan Elina E., MD, senior research officer of the Modern Treatment Methods in Ophthalmology Department 

Rossolimo str., 11A, B, 119021, Moscow

ШколяренкоН. Ю.ShkolyarenkoN. Yu.

Школяренко Наталья Юрьевна, кандидат медицинских наук, старший научный сотрудник отдела современных методов лечения в офтальмологии 

ул. Россолимо, 11а, б, Москва, 119021

Shkolyarenko Natalia Yu., РhD, senior research officer of the Modern Treatment Methods in Ophthalmology Department 

Rossolimo str., 11A, B, 119021, Moscow

ФГБНУ «Научно-исследовательский институт глазных болезней»РоссияResearch Institute of Eye DiseasesRussian Federation202119102021183S630637Copyright © Юсеф Ю., Воробьева М.В., Казарян Э.Э., Школяренко Н.Ю., 20212021Юсеф Ю., Воробьева М.В., Казарян Э.Э., Школяренко Н.Ю.Yusef Y., Vorobyeva M.V., Kazaryan E.E., Shkolyarenko N.Y.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.ophthalmojournal.com/opht/article/view/1633

Катаракта и возрастная макулярная дегенерация (ВМД) являются ведущими причинами слепоты во всем мире. Основными симптомами ВМД являются постепенное снижение остроты зрения до сотых, метаморфопсии, появление центральной скотомы, что снижает качество жизни пациента и приводит к инвалидности. Портативные и стационарные средства оптической реабилитации, такие как лупы для слабовидящих, очки, видеосистемы, громоздки и малофункциональны. Альтернативным вариантом коррекции являются интраокулярные зрительные устройства, позволяющие улучшить качество жизни пациента. В обзоре рассмотрены различные виды интраокулярных имплантатов, в частности система интраокулярного телескопа (интраокулярный миниатюрный телескоп IMT, IOL-VIP, IOL-AMD), линза Френеля, линза Липшица, макулярная линза Scharioth (Scharioth macula lens, SML), EyeMax Mono, ИОЛ LENTIS ® MAX LS-313 MF80. Применение высокотехнологичных устройств для коррекции зрительных нарушений при ВМД открыло новое направление в реабилитации слабовидения. Дальнейшее изучение и внедрение в практику «макулярных» линз последнего поколения позволит повысить качество жизни пациентов с далекозашедшими стадиями ВМД.

Cataracts and age-related macular degeneration (AMD) are the leading causes of blindness worldwide. The main symptoms of AMD are: a gradual decrease in visual acuity to the hundredth, metamorphosis, the appearance of a central scotoma, which reduces the quality of life of the patients and leads to disability. Prosthetic and stationary means of optical rehabilitation, such as magnifiers for the visually impaired, glasses, video systems are cumbersome and poorly functional. An alternative correction option is intraocular vision devices that improve the patient’s quality of life. The review considers various types of intraocular implants, in particular, the intraocular telescope system (intraocular miniature telescope-IMT, IOL-VIP, IOL-AMD), Fresnel lens, Lipschitz lens, Scharioth macular lens (Scharioth macula lens, SML), EyeMax Mono, LENTIS ® MAX IOL LS-313 MF80. The use of high-tech devices for the correction of visual disturbances in AMD has opened a new direction in the rehabilitation of low vision. Further study and implementation of the latest generation of “macular” lenses will improve the quality of life of patients with advanced stages of AMD.

возрастная макулярная дегенерацияинтраокулярная коррекцияинтраокулярные имплантатыустройстваинтраокулярный телескоп IMTIOL-VIPIOL-AMDлинза Френелялинза Липшицамакулярная линза Scharioth (Scharioth macula lensSML)EyeMax Monoвысокодобавочная ИОЛ LENTIS ® MAX LS-313 MF80age-related macular degenerationintraocular correctionintraocular implantsdevicesintraocular telescope IMTIOL-VIPIOL-AMDFresnel lensLipschitz lensScharioth macular lens (Scharioth macula lensSML)EyeMax Monohigh-dose LENTIS ® MAX IOL LS-313 MF80ReferencesAge-Related Macular Degeneration PPP — Updated 2015 (2015). http://www.aao.org/preferred-practice-pattern/age-related-macular-degeneration-ppp-2015. Accessed January 2015.Age-Related Macular Degeneration PPP — Updated 2015 (2015). http://www.aao.org/preferred-practice-pattern/age-related-macular-degeneration-ppp-2015. Accessed January 2015.Schmidt-Erfurth U., Chong V., Loewenstein A., Larsen M., Souied E., Schlingemann R., Eldem B., Monés J., Richard G., Bandello F. European Society of Retina Specialists. Guidelines for the management of neovascular age-related macular degeneration by the European Society of Retina Specialists (EURETINA) Br J Ophthalmol. 2014;98(9):1144–1167. DOI: 10.1136/bjophthalmol-2014-305702.22Schmidt-Erfurth U., Chong V., Loewenstein A., Larsen M., Souied E., Schlingemann R., Eldem B., Monés J., Richard G., Bandello F. European Society of Retina Specialists. Guidelines for the management of neovascular age-related macular degeneration by the European Society of Retina Specialists (EURETINA) Br J Ophthalmol. 2014;98(9):1144–1167. DOI: 10.1136/bjophthalmol-2014-305702.22Mönestam E., Lundqvist B. Long-term visual outcome after cataract surgery: comparison of healthy eyes and eyes with age-related macular degeneration. J Cataract Refract Surg. 2012;38(3):409–414. DOI: 10.1016/j.jcrs.2011.09.041Mönestam E., Lundqvist B. Long-term visual outcome after cataract surgery: comparison of healthy eyes and eyes with age-related macular degeneration. J Cataract Refract Surg. 2012;38(3):409–414. DOI: 10.1016/j.jcrs.2011.09.041Kessel L., Erngaard D., Flesner P., Andresen J., Tendal B., Hjortdal J. Cataract surgery and age-related macular degeneration. An evidence-based update. Acta Ophthalmol. 2015;93(7):593–600. DOI: 10.1111/aos.12665Kessel L., Erngaard D., Flesner P., Andresen J., Tendal B., Hjortdal J. Cataract surgery and age-related macular degeneration. An evidence-based update. Acta Ophthalmol. 2015;93(7):593–600. DOI: 10.1111/aos.12665Van Norren D., Vos J.J. Light damage to the retina: an historical approach. Eye. 2016;30(2):169–172. DOI: 10.1038/eye.2015Van Norren D., Vos J.J. Light damage to the retina: an historical approach. Eye. 2016;30(2):169–172. DOI: 10.1038/eye.2015Downes S.M. Ultraviolet or blue-filtering intraocular lenses: what is the evidence? Eye. 2016;30(2):215–221. DOI: 10.1038/eye.2015.267Downes S.M. Ultraviolet or blue-filtering intraocular lenses: what is the evidence? Eye. 2016;30(2):215–221. DOI: 10.1038/eye.2015.267Steinemann A., Bromundt V., Chellappa S.L., Frey S., Schmidt C., Schlote T., Goldblum D., Cajochen C. Evaluation of Visual Comfort and Mental Effort Under Different Light Conditions for Ultraviolet-Absorbing and Additional Blue-Filtering Intraocular Lenses for Cataract Surgery. Klin Monbl Augenheilkd. 2019;236(4):398–404. DOI: 10.1055/a-0810-0302Steinemann A., Bromundt V., Chellappa S.L., Frey S., Schmidt C., Schlote T., Goldblum D., Cajochen C. Evaluation of Visual Comfort and Mental Effort Under Different Light Conditions for Ultraviolet-Absorbing and Additional Blue-Filtering Intraocular Lenses for Cataract Surgery. Klin Monbl Augenheilkd. 2019;236(4):398–404. DOI: 10.1055/a-0810-0302Armbrecht A.M., Findlay C., Aspinall P.A. Cataract surgery in patients with age-related macular degeneration: one-year outcomes. J Cataract Refract Surg. 2003;29:686–693. DOI: 10.1111/aos.12665Armbrecht A.M., Findlay C., Aspinall P.A. Cataract surgery in patients with age-related macular degeneration: one-year outcomes. J Cataract Refract Surg. 2003;29:686–693. DOI: 10.1111/aos.12665Žiak P., Halička J., Mojžiš Р. Presbyopic lens exchange (PRELEX) cataract surgery outcomes with implantation of a rotationally asymmetric refractive multifocal intraocular lens: femtosecond laser-assisted versus manual phacoemulsification. International ophthalmology. 2019;39(12):2875–2882. DOI: 10.1007/s10792-01901135-3Žiak P., Halička J., Mojžiš Р. Presbyopic lens exchange (PRELEX) cataract surgery outcomes with implantation of a rotationally asymmetric refractive multifocal intraocular lens: femtosecond laser-assisted versus manual phacoemulsification. International ophthalmology. 2019;39(12):2875–2882. DOI: 10.1007/s10792-01901135-3Grzybowski A., Kanclerz P., Tuuminen R. Multifocal intraocular lenses and retinal diseases. Graefes Arch Clin Exp Ophthalmol. 2020;258(4):805–813. DOI: 10.1007/s00417-020-04603-0Grzybowski A., Kanclerz P., Tuuminen R. Multifocal intraocular lenses and retinal diseases. Graefes Arch Clin Exp Ophthalmol. 2020;258(4):805–813. DOI: 10.1007/s00417-020-04603-0Будзинская М.В. Возрастная макулярная дегенерация. Вестник офтальмологии. 2014;130(6):56–61.Budzinskaja M.V. Age-related macular degeneration. Annals of Ophthalmology = Vestnik oftal’mologii. 2014;130(6):56–61 (In Russ.).Gopalakrishnan S., Velu S., Raman R. Low-vision intervention in individuals with age-related macular degeneration. Indian J Ophthalmol. 2020;68(5):886–889. DOI: 10.4103/ijo.IJO_1093_19Gopalakrishnan S., Velu S., Raman R. Low-vision intervention in individuals with age-related macular degeneration. Indian J Ophthalmol. 2020;68(5):886–889. DOI: 10.4103/ijo.IJO_1093_19Dandona L., Dandona R. Revision of visual impairment definitions in the international statistical classification of diseases. BMC Med. 2006; 2006;4:7.Dandona L., Dandona R. Revision of visual impairment definitions in the international statistical classification of diseases. BMC Med. 2006; 2006;4:7.Gopalakrishnan S., Muralidharan A., Susheel S.C., Raman R. Improvement in distance and near visual acuities using low vision devices in diabetic retinopathy. Indian J Ophthalmol. 2017;65:995–998. DOI: 10.4103/ijo. IJO_52_17Gopalakrishnan S., Muralidharan A., Susheel S.C., Raman R. Improvement in distance and near visual acuities using low vision devices in diabetic retinopathy. Indian J Ophthalmol. 2017;65:995–998. DOI: 10.4103/ijo. IJO_52_17Das K., Gopalakrishnan S., Dalan D., Velu S., Ratra V., Ratra D. Factors influencing the choice of low vision devices for visual rehabilitation in Stargardt disease. Clin Exp Optom. 2019;102:426–433. DOI: 10.1111/cxo.12867Das K., Gopalakrishnan S., Dalan D., Velu S., Ratra V., Ratra D. Factors influencing the choice of low vision devices for visual rehabilitation in Stargardt disease. Clin Exp Optom. 2019;102:426–433. DOI: 10.1111/cxo.12867Altpeter E.K., Nguyen N.X. Requirements for low vision magnification aids imagerelated macular degeneration: data from the Tübingen low vision clinic (comparison of 2007–2011 with 1999–2005) Ophthalmologe. 2015;112(11):923–928. DOI: 10.1007/s00347-015-0062-2Altpeter E.K., Nguyen N.X. Requirements for low vision magnification aids imagerelated macular degeneration: data from the Tübingen low vision clinic (comparison of 2007–2011 with 1999–2005) Ophthalmologe. 2015;112(11):923–928. DOI: 10.1007/s00347-015-0062-2Roach L. 5-year results with implanted telescope. EyeNet. 2015;17–18.Roach L. 5-year results with implanted telescope. EyeNet. 2015;17–18.Lazarou J. Implantable Telescope Lens to Treat Macular Degeneration. Available online: Johns Hopkins. www.hopkinsmedicine.org/news/media/releases/implantable_telescope_lens_to_treat_macular_degeneration_available_at_johns_hopkins. Accessed 21 March 2013.Lazarou J. Implantable Telescope Lens to Treat Macular Degeneration. Available online: Johns Hopkins. www.hopkinsmedicine.org/news/media/releases/implantable_telescope_lens_to_treat_macular_degeneration_available_at_johns_hopkins. Accessed 21 March 2013.Dunbar H.M.P., Dhawahir-Scala F.E. A Discussion of Commercially Available Intra-Ocular Telescopic Implants for Patients with Age-Related Macular Degeneration. Ophthalmol Ther 2018;7:33–48. DOI: 10.1007/s40123-018-0129-7Dunbar H.M.P., Dhawahir-Scala F.E. A Discussion of Commercially Available Intra-Ocular Telescopic Implants for Patients with Age-Related Macular Degeneration. Ophthalmol Ther 2018;7:33–48. DOI: 10.1007/s40123-018-0129-7Alió J.L., Mulet E.M., Ruiz J.M., Sánchez M.J., Galal A. Intraocular telescopic lens evaluation in patients with age-related macular degeneration. J Cataract Refract Surg. 2004;30:1177–1189. DOI: 10.1016/j.jcrs.2003.10.038Alió J.L., Mulet E.M., Ruiz J.M., Sánchez M.J., Galal A. Intraocular telescopic lens evaluation in patients with age-related macular degeneration. J Cataract Refract Surg. 2004;30:1177–1189. DOI: 10.1016/j.jcrs.2003.10.038Hudson H.L., Lane S.S., Heier J.S., Stulting R.D., Singerman L., Lichter P.R., Sternberg P., Chang D.F. Implantable miniature telescope for the treatment of visual acuity loss due to end-stage age-related macular degeneration: one-year results. Ophthalmology. 2006;113:1987–2001. DOI: 10.1016/j.ophtha.2006.07.010Hudson H.L., Lane S.S., Heier J.S., Stulting R.D., Singerman L., Lichter P.R., Sternberg P., Chang D.F. Implantable miniature telescope for the treatment of visual acuity loss due to end-stage age-related macular degeneration: one-year results. Ophthalmology. 2006;113:1987–2001. DOI: 10.1016/j.ophtha.2006.07.010Hudson H.L., Stulting R.D., Heier J.S., Lane S.S., Chang D.F., Singerman L.J., Bradford C.A., Leonard R.E., IMT002 Study Group Implantable telescope for end-stage age-related macular degeneration. Long-term visual acuity and safety outcomes. Am J Ophthalmol. 2008;146:664–673. DOI: 10.1016/j.ajo.2008.07.003Hudson H.L., Stulting R.D., Heier J.S., Lane S.S., Chang D.F., Singerman L.J., Bradford C.A., Leonard R.E., IMT002 Study Group Implantable telescope for end-stage age-related macular degeneration. Long-term visual acuity and safety outcomes. Am J Ophthalmol. 2008;146:664–673. DOI: 10.1016/j.ajo.2008.07.003Singer M.A., Amir N., Herro A., Porbandarwalla S.S., Pollard J. Improving quality of life in patients with end-stage age-related macular degeneration: focus on miniature ocular implants. Clin Ophthalmol. 2012;6:33–39. DOI: 10.2147/OPTH.S15028Singer M.A., Amir N., Herro A., Porbandarwalla S.S., Pollard J. Improving quality of life in patients with end-stage age-related macular degeneration: focus on miniature ocular implants. Clin Ophthalmol. 2012;6:33–39. DOI: 10.2147/OPTH.S15028Boyer D., Freund K.B., Regillo C., Levy M.H., Garg S. Long-term (60-month) results for the implantable miniature telescope: efficacy and safety outcomes stratified by age in patients with end-stage age-related macular degeneration. Clin Ophthalmol. 2015;9:1099–1107. DOI: 10.2147/OPTH.S86208Boyer D., Freund K.B., Regillo C., Levy M.H., Garg S. Long-term (60-month) results for the implantable miniature telescope: efficacy and safety outcomes stratified by age in patients with end-stage age-related macular degeneration. Clin Ophthalmol. 2015;9:1099–1107. DOI: 10.2147/OPTH.S86208Dag M.Y., Afrashi F., Nalcaci S. The efficacy of “IOL-Vip Revolution” telescopic intraocular lens in age-related macular degeneration cases with senile cataract. Eur J Ophthalmol. 2019;29:615–620. DOI: 10.1177/1120672118803831Dag M.Y., Afrashi F., Nalcaci S. The efficacy of “IOL-Vip Revolution” telescopic intraocular lens in age-related macular degeneration cases with senile cataract. Eur J Ophthalmol. 2019;29:615–620. DOI: 10.1177/1120672118803831Savaresi G., Pierrottet C.O., Orzalesi N. The IOL-Vip® Software: guidelines for IOLVip® implant. Invest Ophthalmol Vis Sci. 2004;45:2010.Savaresi G., Pierrottet C.O., Orzalesi N. The IOL-Vip® Software: guidelines for IOLVip® implant. Invest Ophthalmol Vis Sci. 2004;45:2010.Orzalesi N., Pierrottet C.O., Zenoni S., Savaresi C. The IOL-Vip System: a double intraocular lens implant for visual rehabilitation of patients with macular disease. Ophthalmology. 2007;114(5):860–865. DOI: 10.1016/j.ophtha.2007.01.005Orzalesi N., Pierrottet C.O., Zenoni S., Savaresi C. The IOL-Vip System: a double intraocular lens implant for visual rehabilitation of patients with macular disease. Ophthalmology. 2007;114(5):860–865. DOI: 10.1016/j.ophtha.2007.01.005Hengerer F.H. Sutureless telescopic IOL for patients with dry AMD. Cataract Refract Surg Today Eur. 2015;2:40–41. DOI: 10.3928/1081597X-20150220-03Hengerer F.H. Sutureless telescopic IOL for patients with dry AMD. Cataract Refract Surg Today Eur. 2015;2:40–41. DOI: 10.3928/1081597X-20150220-03Potgieter F.J., Claoue C.M. Safety and efficacy of an intraocular Fresnel prism intraocular lens in patients with advanced macular disease: initial clinical experience. J Cataract Refract Surg. 2014;40(7):1085–1091. DOI: 10.1016/j.jcrs.2013.10.049Potgieter F.J., Claoue C.M. Safety and efficacy of an intraocular Fresnel prism intraocular lens in patients with advanced macular disease: initial clinical experience. J Cataract Refract Surg. 2014;40(7):1085–1091. DOI: 10.1016/j.jcrs.2013.10.049Lipshitz I., Jacob S., Lamba M., Tiwari R., Kumar D.A., Agarwal A. Mirror telescopic intraocular lens for age-related macular degeneration: design and preliminary clinical results of the Lipshitz macular implant. J Cataract Refract Surg. 2008;34(1):87–94. DOI: 10.1016/j.jcrs.2007.08.031Lipshitz I., Jacob S., Lamba M., Tiwari R., Kumar D.A., Agarwal A. Mirror telescopic intraocular lens for age-related macular degeneration: design and preliminary clinical results of the Lipshitz macular implant. J Cataract Refract Surg. 2008;34(1):87–94. DOI: 10.1016/j.jcrs.2007.08.031Agarwal A., Lipshitz I., Jacob S., Lamba M., Tiwari R., Kumar D.A., Agarwal A. Mirror telescopic intraocular lens for age-related macular degeneration: design and preliminary clinical results of the Lipshitz macular implant. J Cataract Refract Surg. 2008;34(1):87–94. DOI: 10.1016/j.jcrs.2007.08.031Agarwal A., Lipshitz I., Jacob S., Lamba M., Tiwari R., Kumar D.A., Agarwal A. Mirror telescopic intraocular lens for age-related macular degeneration: design and preliminary clinical results of the Lipshitz macular implant. J Cataract Refract Surg. 2008;34(1):87–94. DOI: 10.1016/j.jcrs.2007.08.031Grzybowski A.., Wasinska-Borowiec W., Alio J.L. Intraocular lenses in age-related macular degeneration. Graefe’s Archive for Clinical and Experimental Ophthalmology. 2017;255(9):1687–1696. DOI: 10.1007/s00417-017-3740-8Grzybowski A.., Wasinska-Borowiec W., Alio J.L. Intraocular lenses in age-related macular degeneration. Graefe’s Archive for Clinical and Experimental Ophthalmology. 2017;255(9):1687–1696. DOI: 10.1007/s00417-017-3740-8Scharioth G.B. New add-on intraocular lens for patients with age-related macular degeneration. J Cataract Refract Surg. 2015;41(8):1559–1563. DOI: 10.1016/j.jcrs.2015.07.018Scharioth G.B. New add-on intraocular lens for patients with age-related macular degeneration. J Cataract Refract Surg. 2015;41(8):1559–1563. DOI: 10.1016/j.jcrs.2015.07.018Бикбов М.М., Бурханов Ю.К., Оренбуркина О.И., Бабушкин А.Э. Реабилитация пациентов с артифакией и возрастной макулярной дегенерацией путем имплантации добавочной макулярной линзы Шариота (первый российский опыт). Современные технологии в офтальмологии. 2018;3:20–22. DOI: 10.18008/1816-5095-2019-1S-7-11Bikbov M.M., Burkhanov Yu.K., Orenburkina O.I., Babushkin A.E. Rehabilitation of patients with pseudofakia and age-related macular degeneration by implanting an additional Shariot macular lens (first Russian experience). Modern technology in ophthalmology = Sovremennye tekhnologii v oftal’mologii. 2018;3:20–22 (In Russ.). DOI: 10.18008/1816-5095-2019-1S-7-11Srinivasan S. Implantation of Scharioth macula lens in patients with age-related macular degeneration: results of a prospective European multicentre clinical trial [published correction appears in BMJ Open Ophthalmol. 2019 Aug 9;4(1):e000322corr1]. BMJ Open Ophthalmol. 2019;4(1):000322. Published 2019 Jul 7. DOI: 10.1136/bmjophth-2019-000322Srinivasan S. Implantation of Scharioth macula lens in patients with age-related macular degeneration: results of a prospective European multicentre clinical trial [published correction appears in BMJ Open Ophthalmol. 2019 Aug 9;4(1):e000322corr1]. BMJ Open Ophthalmol. 2019;4(1):000322. Published 2019 Jul 7. DOI: 10.1136/bmjophth-2019-000322Nielsen Niels V., Helgesen A., Muus G. Scharioth Macula Lens for AMD: Quality of Life Study. Presented at: European Society of Cataract and Refractive Surgeons meeting, Vienna, Austria, September 22-26, 2018.Nielsen Niels V., Helgesen A., Muus G. Scharioth Macula Lens for AMD: Quality of Life Study. Presented at: European Society of Cataract and Refractive Surgeons meeting, Vienna, Austria, September 22-26, 2018.Borkenstein A.F., Borkenstein E.M. Cataract surgery with implantation of a highadd intraocular lens LENTIS® MAX LS-313 MF80 in end-stage, age-related macular degeneration: A case report of magnifying surgery. Clin Case Rep. 2018;7(1):74–78. DOI: 10.1002/ccr3.1912Borkenstein A.F., Borkenstein E.M. Cataract surgery with implantation of a highadd intraocular lens LENTIS® MAX LS-313 MF80 in end-stage, age-related macular degeneration: A case report of magnifying surgery. Clin Case Rep. 2018;7(1):74–78. DOI: 10.1002/ccr3.1912Borkenstein A.F., Borkenstein E.M. Four Years of Observation to Evaluate Autonomy and Quality of Life after Implantation of a High-Add Intraocular Lens in AgeRelated Macular Degeneration Patients. Case Rep Ophthalmol. 2020;11(2):448–456. DOI: 10.1159/000508914Borkenstein A.F., Borkenstein E.M. Four Years of Observation to Evaluate Autonomy and Quality of Life after Implantation of a High-Add Intraocular Lens in AgeRelated Macular Degeneration Patients. Case Rep Ophthalmol. 2020;11(2):448–456. DOI: 10.1159/000508914Qureshi M.A., Robbie S.J., Hengerer F.H. Consecutive case series of 244 age-related macular degeneration patients undergoing implantation with an extended macular vision IOL. Eur J Ophthalmol 2018;28:198–203. DOI: 10.5301/ejo.5001052Qureshi M.A., Robbie S.J., Hengerer F.H. Consecutive case series of 244 age-related macular degeneration patients undergoing implantation with an extended macular vision IOL. Eur J Ophthalmol 2018;28:198–203. DOI: 10.5301/ejo.5001052Grzybowski A., Wang J., Mao F., Wang D., Wang N. Intraocular vision-improving devices in age-related macular degeneration. Ann Transl Med. 2020;8(22):1549. DOI: 10.21037/atm-20-5851Grzybowski A., Wang J., Mao F., Wang D., Wang N. Intraocular vision-improving devices in age-related macular degeneration. Ann Transl Med. 2020;8(22):1549. DOI: 10.21037/atm-20-5851

The authors declare that there are no conflicts of interest present.